0001214659-18-003060.txt : 20180426
0001214659-18-003060.hdr.sgml : 20180426
20180426180750
ACCESSION NUMBER: 0001214659-18-003060
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180425
FILED AS OF DATE: 20180426
DATE AS OF CHANGE: 20180426
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CHEN ISAN
CENTRAL INDEX KEY: 0001586218
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35921
FILM NUMBER: 18780077
MAIL ADDRESS:
STREET 1: C/O MIRATI THERAPEUTICS, INC.
STREET 2: 9393 TOWNE CENTRE DRIVE, STE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mirati Therapeutics, Inc.
CENTRAL INDEX KEY: 0001576263
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 462693615
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9393 TOWNE CENTRE DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-332-3410
MAIL ADDRESS:
STREET 1: 9393 TOWNE CENTRE DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
marketforms-41802.xml
PRIMARY DOCUMENT
X0306
4
2018-04-25
0001576263
Mirati Therapeutics, Inc.
MRTX
0001586218
CHEN ISAN
C/O MIRATI THERAPEUTICS, INC.
9393 TOWNE CENTRE DRIVE, STE 200
SAN DIEGO
CA
92121
false
true
false
false
EVP, Chief Medical Officer
Common Stock
2018-04-25
4
M
false
2
5.40
A
18800
D
Common Stock
2018-04-25
4
M
false
10124
15.79
A
28924
D
Common Stock
2018-04-25
4
M
false
412
17.41
A
29336
D
Common Stock
2018-04-25
4
M
false
2500
21.51
A
31836
D
Common Stock
110
I
By Chen Living Trust
Employee Stock Option (Right to Buy)
5.40
2018-04-25
4
M
false
2
0
D
2027-01-25
Common Stock
2
49998
D
Employee Stock Option (Right to Buy)
15.79
2018-04-25
4
M
false
10124
0
D
2023-11-07
Common Stock
10124
96668
D
Employee Stock Option (Right to Buy)
17.41
2018-04-25
4
M
false
412
0
D
2024-05-20
Common Stock
412
6188
D
Employee Stock Option (Right to Buy)
21.51
2018-04-25
4
M
false
2500
0
D
2025-02-03
Common Stock
2500
27500
D
1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of theshares subject to the Option shall vest each month thereafter until fully vested.
/s/ Vickie Reed, Attorney-in-Fact
2018-04-26